AdvertisementFDA Approves Esketamine Nasal Spray For Hard-To-Treat Depression 03:40Download AudioResumeMarch 05, 2019Jon HamiltonfacebookEmailSpravato, the brand name for esketamine, a newly approved option for treatment-resistant depression. (Janssen Pharmaceutica)
